BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Fuji
Johnson and Johnson
Healthtrust
Argus Health
Citi
McKesson
Accenture
Deloitte
Cerilliant

Generated: January 19, 2018

DrugPatentWatch Database Preview

Crisaborole - Generic Drug Details

« Back to Dashboard

What are the generic sources for crisaborole and what is the scope of crisaborole freedom to operate?

Crisaborole
is the generic ingredient in one branded drug marketed by Anacor Pharms Inc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Crisaborole has one hundred and six patent family members in twenty-two countries.

One supplier is listed for this compound.
Summary for crisaborole
International Patents:106
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 46
Clinical Trials: 4
Patent Applications: 35
Drug Prices:see low prices
DailyMed Link:crisaborole at DailyMed
Pharmacology for crisaborole

US Patents and Regulatory Information for crisaborole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for crisaborole

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,722,917 Boron-containing small molecules ➤ Subscribe
9,572,823 Boron-containing small molecules ➤ Subscribe
7,582,621 Boron-containing small molecules ➤ Subscribe
9,549,938 Boron-containing small molecules ➤ Subscribe
9,029,353 Boron-containing small molecules as anti-inflammatory agents ➤ Subscribe
7,767,657 Boron-containing small molecules ➤ Subscribe
8,889,656 Boron-containing small molecules ➤ Subscribe
8,440,642 Boron-containing small molecules ➤ Subscribe
8,115,026 Boron-containing small molecules ➤ Subscribe
9,566,290 Boron-containing small molecules ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for crisaborole

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Cantor Fitzgerald
Johnson and Johnson
Novartis
Cipla
McKinsey
Citi
Dow
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot